D2 #PROSCA22 in beautiful Athens
silke gillessen outlines the evidence for #docetaxel in #mHSPC
Is volume of disease important? Does it matter if synchronous v metachronous disease? Triple v doublet therapy? Mirrors of Medicine Nick James

Nick James on the association between volume & radiotherapy in #metastaticprostatecancer Is 4 the magic no for mets? How important is LN burden? Can men with mets be cured? 🤔 #PROSCA22 Mirrors of Medicine

Pr Amit Bahl discusses cardiovascular and bone health in men with #prostatecancer Data is conflicting for CVS & studies have different endpoints #PROSCA22 Mirrors of Medicine

evacomperat on the updated #WHOGuidelines2022 - its variants not sub-type, cribriform is prognostic, molecular pathology expertise is increasingly important for optimal patient outcomes #PROSCA22 Mirrors of Medicine

Great session on the future for #prostatecancer treatment. Proper blue horizon stuff! But I can't tell you - join us next year to find out more...😉🤫 evacomperat @ashutoshtew Alberto Bossi Eleni Efstathiou Ash Tewari, MD #PROSCA22 Mirrors of Medicine